Stock DNA
Pharmaceuticals & Biotechnology
CNY 35,331 Million (Large Cap)
19.00
NA
1.63%
-0.50
12.85%
2.61
Revenue and Profits:
Net Sales:
1,886 Million
(Quarterly Results - Sep 2025)
Net Profit:
267 Million
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
4.38%
0%
4.38%
6 Months
12.07%
0%
12.07%
1 Year
-1.78%
0%
-1.78%
2 Years
19.03%
0%
19.03%
3 Years
59.29%
0%
59.29%
4 Years
16.17%
0%
16.17%
5 Years
17.46%
0%
17.46%
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
7.32%
EBIT Growth (5y)
-1.21%
EBIT to Interest (avg)
66.81
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.51
Sales to Capital Employed (avg)
0.59
Tax Ratio
6.63%
Dividend Payout Ratio
44.22%
Pledged Shares
0
Institutional Holding
0.07%
ROCE (avg)
28.47%
ROE (avg)
18.30%
Valuation key factors
Factor
Value
P/E Ratio
19
Industry P/E
Price to Book Value
2.66
EV to EBIT
22.51
EV to EBITDA
18.26
EV to Capital Employed
4.35
EV to Sales
3.65
PEG Ratio
NA
Dividend Yield
2.20%
ROCE (Latest)
19.34%
ROE (Latest)
14.14%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Mildly Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Bullish
Bullish
Dow Theory
Mildly Bearish
No Trend
OBV
Mildly Bullish
No Trend
Shareholding Snapshot : Mar 2017
Shareholding Compare (%holding) 
Majority shareholders
Foreign Institutions
Domestic Funds
Held in 0 Schemes (0%)
Foreign Institutions
Held by 1 Foreign Institutions (0.07%)
Strategic Entities with highest holding
Highest Public shareholder
Quarterly Results Snapshot (Consolidated) - Sep'25 - QoQ
Sep'25
Jun'25
Change(%)
Net Sales
1,885.90
2,201.50
-14.34%
Operating Profit (PBDIT) excl Other Income
244.40
452.60
-46.00%
Interest
0.00
0.00
Exceptional Items
0.00
0.00
Consolidate Net Profit
266.60
576.50
-53.76%
Operating Profit Margin (Excl OI)
129.60%
173.00%
-4.34%
USD in Million.
Net Sales
QoQ Growth in quarter ended Sep 2025 is -14.34% vs -9.62% in Jun 2025
Consolidated Net Profit
QoQ Growth in quarter ended Sep 2025 is -53.76% vs -7.49% in Jun 2025
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
7,491.40
7,890.40
-5.06%
Operating Profit (PBDIT) excl Other Income
1,662.90
2,285.80
-27.25%
Interest
21.70
61.00
-64.43%
Exceptional Items
-20.50
-31.10
34.08%
Consolidate Net Profit
1,804.30
2,376.50
-24.08%
Operating Profit Margin (Excl OI)
184.40%
256.40%
-7.20%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is -5.06% vs 11.85% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -24.08% vs 51.11% in Dec 2023
About Jiangsu Yuyue Medical Equipment & Supply Co., Ltd. 
Jiangsu Yuyue Medical Equipment & Supply Co., Ltd.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available






